Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Coles

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2002
Neutralising antibodies to the beta interferonsA J Coles
International MS Journal|August 10, 2007
Rationale for cytotoxic monoclonal antibodies in MSB S Simpson, A J Coles
International MS Journal|November 3, 2009
Spotlight on alemtuzumabJ L Jones, A J Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapyA J Coles, M G Wing, D A Compston
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2013
First use of alemtuzumab in Balo's concentric sclerosis: a case reportJ W L Brown, A J Coles, J L Jones
Neurobiology of Disease|October 20, 2010
Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferationR Laguna Goya, R Busch, R Mathur, et al.
Journal of Neuroimmunology|April 22, 2019
The immunological response to traumatic brain injuryE J Needham, A Helmy, E R Zanier, et al.
Journal of Immunological Methods|October 5, 2021
A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuriesR J Digby, V Coppard, H S Mousa, et al.
Journal of Neuroimmunology|March 8, 2006
An investigation of auto-reactivity after head injuryA L Cox, A J Coles, J Nortje, et al.
Annals of Neurology|September 11, 1999
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosisA J Coles, M G Wing, P Molyneux, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2002
Neutralising antibodies to the beta interferonsA J Coles
International MS Journal|August 10, 2007
Rationale for cytotoxic monoclonal antibodies in MSB S Simpson, A J Coles
International MS Journal|November 3, 2009
Spotlight on alemtuzumabJ L Jones, A J Coles
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapyA J Coles, M G Wing, D A Compston
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2013
First use of alemtuzumab in Balo's concentric sclerosis: a case reportJ W L Brown, A J Coles, J L Jones
Neurobiology of Disease|October 20, 2010
Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferationR Laguna Goya, R Busch, R Mathur, et al.
Journal of Neuroimmunology|April 22, 2019
The immunological response to traumatic brain injuryE J Needham, A Helmy, E R Zanier, et al.
Journal of Immunological Methods|October 5, 2021
A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuriesR J Digby, V Coppard, H S Mousa, et al.
Journal of Neuroimmunology|March 8, 2006
An investigation of auto-reactivity after head injuryA L Cox, A J Coles, J Nortje, et al.
Annals of Neurology|September 11, 1999
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosisA J Coles, M G Wing, P Molyneux, et al.
Pageof 2